Martina Álvarez

1.5k total citations · 1 hit paper
41 papers, 840 citations indexed

About

Martina Álvarez is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Martina Álvarez has authored 41 papers receiving a total of 840 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 16 papers in Cancer Research and 15 papers in Molecular Biology. Recurrent topics in Martina Álvarez's work include Cancer Genomics and Diagnostics (8 papers), HER2/EGFR in Cancer Research (6 papers) and Cancer Cells and Metastasis (5 papers). Martina Álvarez is often cited by papers focused on Cancer Genomics and Diagnostics (8 papers), HER2/EGFR in Cancer Research (6 papers) and Cancer Cells and Metastasis (5 papers). Martina Álvarez collaborates with scholars based in Spain, United States and Sweden. Martina Álvarez's co-authors include Emilio Alba, Elísabeth Pérez-Ruiz, Nuria Ribelles, Casilda Llácer, Ignacio Melero, Pedro Berraondo, Vanesa de Luque, Maite Álvarez, María E. Rodríguez-Ruiz and Luna Minute and has published in prestigious journals such as Nature, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Martina Álvarez

38 papers receiving 832 citations

Hit Papers

Prophylactic TNF blockade uncouples efficacy and toxicity... 2019 2026 2021 2023 2019 100 200 300

Peers

Martina Álvarez
Wen Liu China
Anupma Nayak United States
Ethel R. Pereira United States
Sayali Onkar United States
Lars Tharun Germany
Massimiliano Mellone United Kingdom
Chad A. Glazer United States
Wen Liu China
Martina Álvarez
Citations per year, relative to Martina Álvarez Martina Álvarez (= 1×) peers Wen Liu

Countries citing papers authored by Martina Álvarez

Since Specialization
Citations

This map shows the geographic impact of Martina Álvarez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martina Álvarez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martina Álvarez more than expected).

Fields of papers citing papers by Martina Álvarez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martina Álvarez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martina Álvarez. The network helps show where Martina Álvarez may publish in the future.

Co-authorship network of co-authors of Martina Álvarez

This figure shows the co-authorship network connecting the top 25 collaborators of Martina Álvarez. A scholar is included among the top collaborators of Martina Álvarez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martina Álvarez. Martina Álvarez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berciano‐Guerrero, Miguel‐Ángel, Rocío Lavado-Valenzuela, Édouard Auclin, et al.. (2025). Association of gut microbiota and immune gene expression with response to targeted therapy in BRAF mutated melanoma. Scientific Reports. 15(1). 25430–25430. 1 indexed citations
2.
Laborda-Illanes, Aurora, Lidia Sánchez‐Alcoholado, Bella Pajares, et al.. (2024). Exploring the Relationship between MicroRNAs, Intratumoral Microbiota, and Breast Cancer Progression in Patients with and without Metastasis. International Journal of Molecular Sciences. 25(13). 7091–7091. 5 indexed citations
3.
Álvarez, Martina, et al.. (2024). The Role of Immunohistochemistry as a Surrogate Marker in Molecular Subtyping and Classification of Bladder Cancer. Diagnostics. 14(22). 2501–2501. 3 indexed citations
4.
Berciano‐Guerrero, Miguel‐Ángel, Manuel Cobo, Elísabeth Pérez-Ruiz, et al.. (2024). Oncogene-addicted solid tumors and microbiome—lung cancer as a main character: a narrative review. Translational Lung Cancer Research. 13(8). 2050–2066. 1 indexed citations
5.
Carrasco, Estela, Anna Suñol, Carmen Segrelles, et al.. (2023). Early Diagnosis of Oral Cancer and Lesions in Fanconi Anemia Patients: A Prospective and Longitudinal Study Using Saliva and Plasma. Cancers. 15(6). 1871–1871. 12 indexed citations
6.
Rodríguez, A., Caterina Aversa, Leonardo Rodríguez‐Carunchio, et al.. (2023). 2398P Are fibroblast growth factor receptor 3 (FGFR3) alterations a possible predictive factor for platinum-based chemotherapy and immunotherapy in metastatic urothelial carcinoma (MUC)?. Annals of Oncology. 34. S1220–S1221. 1 indexed citations
7.
Godoy-Ortíz, Ana, Rocío Lavado-Valenzuela, Martina Álvarez, et al.. (2023). Comparative study of droplet-digital PCR and absolute Q digital PCR for ctDNA detection in early-stage breast cancer patients. Clinica Chimica Acta. 552. 117673–117673. 15 indexed citations
9.
Álvarez, Martina, et al.. (2019). Causes of death in patients with locally advanced head and neck cancer treated with radiotherapy and systemic therapy. BMC Cancer. 19(1). 1241–1241. 10 indexed citations
10.
Álvarez, Martina, Luís Vicioso, Cristina Hernándo, et al.. (2019). Detection of TP53 and PIK3CA Mutations in Circulating Tumor DNA Using Next-Generation Sequencing in the Screening Process for Early Breast Cancer Diagnosis. Journal of Clinical Medicine. 8(8). 1183–1183. 44 indexed citations
11.
Pérez-Ruiz, Elísabeth, Antonio Rueda, Francisco Rivas‐Ruiz, et al.. (2017). Expression and Prognostic Value of Oestrogen Receptor Beta in Colorectal Cancer. Pathology & Oncology Research. 24(4). 871–879. 3 indexed citations
12.
Sánchez‐Muñoz, Alfonso, Luís Vicioso, Ángela Santonja, et al.. (2017). Male breast cancer: correlation between immunohistochemical subtyping and PAM50 intrinsic subtypes, and the subsequent clinical outcomes. Modern Pathology. 31(2). 299–306. 18 indexed citations
13.
Gómez‐Millán, Jaime, Bella Pajares, Amancio Carnero, et al.. (2016). Subcellular localisation of pMEK has a different prognosis in locally advanced head and neck cancer treated with concomitant radiochemotherapy. BMC Cancer. 16(1). 829–829. 1 indexed citations
14.
Prat, Aleix, Patricia Galván, Begoña Jiménez, et al.. (2015). Prediction of Response to Neoadjuvant Chemotherapy Using Core Needle Biopsy Samples with the Prosigna Assay. Clinical Cancer Research. 22(3). 560–566. 64 indexed citations
15.
Granados‐Durán, Pablo, et al.. (2015). Neuroinflammation Induced by Intracerebroventricular Injection of Microbial Neuraminidase. Frontiers in Medicine. 2. 14–14. 21 indexed citations
16.
Rueda, Antonio, David Olmos, Luís Vicioso, et al.. (2014). Role of vascular endothelial growth factor C in classical Hodgkin lymphoma. Leukemia & lymphoma. 56(5). 1286–1294. 8 indexed citations
17.
Pajares, Bella, José Trigo, Martina Álvarez, et al.. (2013). Concurrent radiotherapy plus epidermal growth factor receptor inhibitors in patients with human papillomavirus-related head and neck cancer. Clinical & Translational Oncology. 16(4). 418–424. 8 indexed citations
18.
Pérez-Ruiz, Elísabeth, Maximino Redondo, Martina Álvarez, et al.. (2012). Immunohistochemical expression of cyclooxygenase-2 in patients with advanced cancer of the larynx who have undergone induction chemotherapy with the intention of preserving phonation. Clinical & Translational Oncology. 14(9). 682–688. 7 indexed citations
19.
Vicioso, Luís, et al.. (2011). Stromal expression of vascular endothelial growth factor C is relevant to predict sentinel lymph node status in melanomas. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 458(5). 621–630. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026